SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, today reported positive data from a multicenter clinical study (NCT 04708951) comparing the adenoma detection rate (ADR) of its FDA-cleared .
In this updated edition of Answers to Anorexia (FriesenPress, September 24), psychiatrist James M. Greenblatt, MD, applies his extensive experience as an eating disorder expert of over 20 years and the very latest in scientific research to present a novel treatment model for anorexia nervosa.
A global leader in e-health technology, CompuGroup Medical (CGM) worked this summer with Timorese scientists and Australia's Menzies School of Health Research to improve patient care and streamline the diagnostic laboratory process in the newly independent nation of Timor-Leste.
The White House's six-pronged COVID-19 action plan takes steps to protect the nation's economic recovery from the global pandemic, but large employers with 100+ employees may be at risk if they're unable to comply with the government's new vaccine and diagnostic testing mandate.
A new Orthotist and Prosthetist Assistant Studies (OPA) specialization is being offered within the Bachelor of Science in Exercise Science (EXS) degree program in the Department of Human Movement Science at Oakland University.
The original NoseFrida nasal aspirator is a huge success in the US and globally selling millions of units each year, making it one of the most popular household staples during cold and flu season.
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, the first patient implant in a U.S.
Medtronic plc (NYSE:MDT), the global leader in medical technology, had the first gynecological (GYN) procedures with the Hugo™ robotic-assisted surgery (RAS) system.
Seaga introduces ScrubTrax as the driving force behind Seaga's new line of healthcare solutions. It's an intelligent locker system equipped with features designed to give users access to their personalized scrubs.
WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has received the License of Manufacturing Permit from German health authorities for its drug product facility (DP7) in Leverkusen, Germany.